Nephros, Inc. (NEPH) Stock Forecast
NEPH analyst forecast
as of October 18, 2026- Analyst consensus
- Buy 4.00 / 5 from 3 analysts
- Price target
- $6.25 average of analyst targets
- Upside to target
- +71.2% from the latest close
- Next earnings
- November 5, 2026 EPS estimate $0.02
- 52-week range
- $2.78 – $5.79
NEPH analyst ratings
3 analystsNumber of analysts at each rating.
NEPH price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
NEPH earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.03 | $0.03 | $0.03 | $0.03 | 0.0% | 1 |
| Current fiscal year (2026) | $0.17 | $0.17 | $0.17 | $0.11 | +54.5% | 1 |
| Next fiscal year (2027) | $0.21 | $0.21 | $0.21 | $0.17 | +23.5% | 1 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
NEPH revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $5.5M | $5.3M | $5.6M | +15.3% | 3 |
| Current fiscal year (2026) | $22.1M | $21.7M | $22.3M | +17.8% | 3 |
| Next fiscal year (2027) | $25.7M | $25.5M | $25.8M | +15.9% | 2 |
NEPH EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
NEPH revenue: reported and forecast
NEPH EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $0.03 | $0.03 | $0.02 | $0.02 | $0.03 | +20.0% | 1 up · 1 down |
| Current fiscal year (2026) | $0.04 | $0.04 | $0.04 | $0.17 | $0.17 | +277.8% | 0 up · 1 down |
| Next fiscal year (2027) | $0.10 | $0.10 | $0.10 | $0.14 | $0.21 | +110.0% | 0 up · 1 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
NEPH earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; NEPH beat in 10 of 12.
What analysts expect from NEPH
3 analysts cover Nephros; their consensus rating is buy (4.00 on a 1–5 scale, where 5 is a strong buy). The average price target is $6.25, 71.2% above the latest close of $3.65. Analysts expect earnings of $0.17 per share for 2026, +54.5% from a year earlier. For 2027 the average estimate is $0.21 per share on revenue of $25.7 million. Nephros beat the EPS estimate in 10 of the last 12 quarters.
Related: NEPH income statement, NEPH key metrics, NEPH chart. See the NEPH stock overview for the latest quote and news.
NEPH forecast FAQ
What is Nephros's price target?
The average analyst price target for Nephros is $6.25, 71.2% above the latest close of $3.65.
Is Nephros a buy, hold or sell?
Of 3 analysts covering Nephros, 1 rate it a strong buy, 1 a buy, 1 a hold, 0 a sell and 0 a strong sell, a consensus of buy. Ratings are opinions, not a recommendation from Quotelinks.
What is Nephros's EPS forecast?
Analysts forecast $0.17 per share for 2026 (range $0.17 to $0.17); for 2027 the estimate is $0.21.
What is Nephros's revenue forecast?
The average revenue estimate for 2026 is $22.1 million, growth of 17.8%; for 2027 it is $25.7 million.
When does Nephros report earnings?
Nephros is expected to report results for the quarter ending September 30, 2026 on November 5, 2026 after the market closes; the EPS estimate is $0.02.
Does Nephros usually beat earnings estimates?
Nephros reported EPS at or above the analyst estimate in 10 of the last 12 quarters.